ALLR

Latest SEC Filings & News for ALLR

2 most recent filings and news items mentioning ALLR. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/ALLR/news?limit=20"

Pull ALLR filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

LegalJul 1, 2026Positive

Allarity Receives Key U.S. Patent for Stenoparib DRP Companion Diagnostic

Allarity Therapeutics announced the USPTO has granted a key patent covering its stenoparib DRP companion diagnostic. This milestone secures exclusivity for stenoparib until 2042, validating the company's strategy for precision oncology and supporting FDA approval efforts.

View filing at SEC.gov →

RegulatoryJun 22, 2026Positive

Allarity to present Phase 2 stenoparib trial poster at ESMO congress

Allarity Therapeutics will present a Trial-in-Progress poster on its Phase 2 stenoparib study for platinum-resistant ovarian cancer at the ESMO Gynaecological Cancers Congress in Copenhagen. The presentation showcases the clinical rationale for the dual PARP and WNT pathway inhib

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.